Your browser doesn't support javascript.
loading
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.
Hui, Edwin P; Ma, Brigette B Y; Chan, K C Allen; Chan, Charles M L; Wong, Cesar S C; To, Ka Fai; Chan, Anthony W H; Tung, Stewart Y; Ng, Wai-Tong; Cheng, Ashley C; Lee, Victor H F; Chan, Stephen L; Loong, Herbert H F; Kam, Michael K M; Leung, Sing-Fai; Ho, Rosalie; Mo, Frankie; Ngan, Roger K C; Chan, Anthony T C.
Afiliación
  • Hui EP; Partner State Key Laboratory of Oncology in South China, Department of Clinical Oncology, Sir Y.K. Pao Center for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
  • Ma BB; Partner State Key Laboratory of Oncology in South China, Department of Clinical Oncology, Sir Y.K. Pao Center for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
  • Chan KC; Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Chan CM; Partner State Key Laboratory of Oncology in South China, Department of Clinical Oncology, Sir Y.K. Pao Center for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
  • Wong CS; Department of Health Technology and Informatics, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Hong Kong SAR, China.
  • To KF; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Chan AW; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Tung SY; Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong SAR, China.
  • Ng WT; Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
  • Cheng AC; Department of Oncology, Princess Margaret Hospital, Hong Kong SAR, China.
  • Lee VH; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong SAR, China.
  • Chan SL; Partner State Key Laboratory of Oncology in South China, Department of Clinical Oncology, Sir Y.K. Pao Center for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
  • Loong HH; Partner State Key Laboratory of Oncology in South China, Department of Clinical Oncology, Sir Y.K. Pao Center for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
  • Kam MK; Partner State Key Laboratory of Oncology in South China, Department of Clinical Oncology, Sir Y.K. Pao Center for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
  • Leung SF; Partner State Key Laboratory of Oncology in South China, Department of Clinical Oncology, Sir Y.K. Pao Center for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
  • Ho R; Partner State Key Laboratory of Oncology in South China, Department of Clinical Oncology, Sir Y.K. Pao Center for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
  • Mo F; Partner State Key Laboratory of Oncology in South China, Department of Clinical Oncology, Sir Y.K. Pao Center for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
  • Ngan RK; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China.
  • Chan AT; Partner State Key Laboratory of Oncology in South China, Department of Clinical Oncology, Sir Y.K. Pao Center for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
Cancer ; 121(16): 2720-9, 2015 Aug 15.
Article en En | MEDLINE | ID: mdl-25946469
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: ADN Viral / Neoplasias Nasofaríngeas / Herpesvirus Humano 4 / Polimorfismo de Nucleótido Simple / Proteínas de Unión al ADN / Endonucleasas Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2015 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: ADN Viral / Neoplasias Nasofaríngeas / Herpesvirus Humano 4 / Polimorfismo de Nucleótido Simple / Proteínas de Unión al ADN / Endonucleasas Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2015 Tipo del documento: Article País de afiliación: China